TriSalus 생명 과학, Inc.
US ˙ NasdaqGM ˙ US89680M1018

SecurityTLSI / TriSalus Life Sciences, Inc.
InstitutionState Street Corp
Latest Disclosed Ownership328,020 shares
Latest Disclosed Value $ 1,312,080
State Street Corp reports 23.96% increase in ownership of TLSI / TriSalus Life Sciences, Inc.

On May 15, 2026 - State Street Corp filed a 13F-HR form disclosing ownership of 328,020 shares of TriSalus Life Sciences, Inc. (US:TLSI) valued at $1,312,080 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 264,628 shares of TriSalus Life Sciences, Inc.. This represents a change in shares of 23.96% during the quarter. The current value of the position is $1,039,823 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F TRISALUS LIFE SCIENCES COM 89680M101 328,020 63,392 23.96 1,312 -28.97 0.0000
2026-02-13 2025-12-31 13F TRISALUS LIFE SCIENCES COM 89680M101 264,628 71,995 37.37 1,847 106.37 0.0001
2025-11-14 2025-09-30 13F TRISALUS LIFE SCIENCES COM 89680M101 192,633 77,036 66.64 896 42.06 0.0000
2025-08-14 2025-06-30 13F TRISALUS LIFE SCIENCES COM 89680M101 115,597 95,397 472.26 630 467.57 0.0000
2025-05-15 2025-03-31 13F TRISALUS LIFE SCIENCES COM 89680M101 20,200 0 0.00 112 9.90 0.0000
2025-02-14 2024-12-31 13F TRISALUS LIFE SCIENCES COM 89680M101 20,200 9,100 81.98 101 98.04 0.0000
2024-11-14 2024-09-30 13F TRISALUS LIFE SCIENCES COM 89680M101 11,100 0 0.00 51 -16.39 0.0000
2024-08-14 2024-06-30 13F TRISALUS LIFE SCIENCES COM 89680M101 11,100 11,100 61 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.